Clough Capital Partners’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Other funds holding WVE
RCM
RG
BG
RI
ACH
Clough Capital Partners's WVE Position: Q4 2019 in Review
Clough Capital Partners sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 59,076 shares — an estimated $1.21M sold.
Clough Capital Partners first reported a position in WVE in Q4 2015 and held it in 16 quarters. The position peaked at $10.9M in Q1 2017. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.
- Clough Capital Partners reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
- Clough Capital Partners sold 59,076 Wave Life Sciences shares in Q4 2019, an estimated $1.21M.
- Clough Capital Partners first reported a position in Wave Life Sciences in Q4 2015 and held it in 16 quarters.
- Clough Capital Partners's Wave Life Sciences position peaked at $10.9M in Q1 2017.
- 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.
Based on Clough Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.